Cargando…
C3 Glomerulopathy and Atypical Hemolytic Uremic Syndrome: Two Important Manifestations of Complement System Dysfunction
The advances in our understanding of the alternative pathway have emphasized that uncontrolled hyperactivity of this pathway causes 2 distinct disorders that adversely impact the kidney. In the so-called atypical hemolytic uremic syndrome (aHUS), renal dysfunction occurs along with thrombocytopenia,...
Autores principales: | Bajwa, Ravneet, DePalma, John A., Khan, Taimoor, Cheema, Anmol, Kalathil, Sheila A., Hossain, Mohammad A., Haroon, Attiya, Madhurima, Anne, Zheng, Min, Nayer, Ali, Asif, Arif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836224/ https://www.ncbi.nlm.nih.gov/pubmed/29594148 http://dx.doi.org/10.1159/000486848 |
Ejemplares similares
-
Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab
por: Asif, Arif, et al.
Publicado: (2016) -
Efficacy of Eculizumab in Coexisting Complement C3 Glomerulopathy and Atypical Hemolytic Uremic Syndrome
por: Busutti, Marco, et al.
Publicado: (2020) -
Case Report: Lipoprotein Glomerulopathy Complicated by Atypical Hemolytic Uremic Syndrome
por: Kollbrunner, Lara, et al.
Publicado: (2021) -
Complement activation in atypical hemolytic uremic syndrome and
scleroderma renal crisis: a critical analysis of pathophysiology
por: Zuckerman, Roman, et al.
Publicado: (2018) -
Complement factor H and the hemolytic uremic syndrome
por: Atkinson, John P., et al.
Publicado: (2007)